These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 27474525)

  • 1. Genomic approaches to diagnose rare bone disorders.
    Falardeau F; Camurri MV; Campeau PM
    Bone; 2017 Sep; 102():5-14. PubMed ID: 27474525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Next-generation sequencing applied to rare diseases genomics.
    Danielsson K; Mun LJ; Lordemann A; Mao J; Lin CH
    Expert Rev Mol Diagn; 2014 May; 14(4):469-87. PubMed ID: 24702023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole-exome sequencing as a diagnostic tool: current challenges and future opportunities.
    Tetreault M; Bareke E; Nadaf J; Alirezaie N; Majewski J
    Expert Rev Mol Diagn; 2015 Jun; 15(6):749-60. PubMed ID: 25959410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic yield of rare skeletal dysplasia conditions in the radiogenomics era.
    Sabir AH; Morley E; Sheikh J; Calder AD; Beleza-Meireles A; Cheung MS; Cocca A; Jansson M; Lillis S; Patel Y; Yau S; Hall CM; Offiah AC; Irving M
    BMC Med Genomics; 2021 Jun; 14(1):148. PubMed ID: 34092239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical sequencing: is WGS the better WES?
    Meienberg J; Bruggmann R; Oexle K; Matyas G
    Hum Genet; 2016 Mar; 135(3):359-62. PubMed ID: 26742503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Next-generation diagnostics: gene panel, exome, or whole genome?
    Sun Y; Ruivenkamp CA; Hoffer MJ; Vrijenhoek T; Kriek M; van Asperen CJ; den Dunnen JT; Santen GW
    Hum Mutat; 2015 Jun; 36(6):648-55. PubMed ID: 25772376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opportunities and challenges of whole-genome and -exome sequencing.
    Petersen BS; Fredrich B; Hoeppner MP; Ellinghaus D; Franke A
    BMC Genet; 2017 Feb; 18(1):14. PubMed ID: 28193154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Exome and Genome Sequencing Technologies for the Complete Capture of Protein-Coding Regions.
    Lelieveld SH; Spielmann M; Mundlos S; Veltman JA; Gilissen C
    Hum Mutat; 2015 Aug; 36(8):815-22. PubMed ID: 25973577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole-genome sequencing is more powerful than whole-exome sequencing for detecting exome variants.
    Belkadi A; Bolze A; Itan Y; Cobat A; Vincent QB; Antipenko A; Shang L; Boisson B; Casanova JL; Abel L
    Proc Natl Acad Sci U S A; 2015 Apr; 112(17):5473-8. PubMed ID: 25827230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploiting the potential of next-generation sequencing in genomic medicine.
    Pinto AM; Ariani F; Bianciardi L; Daga S; Renieri A
    Expert Rev Mol Diagn; 2016 Sep; 16(9):1037-47. PubMed ID: 27574853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges in the diagnosis and discovery of rare genetic disorders using contemporary sequencing technologies.
    Seaby EG; Ennis S
    Brief Funct Genomics; 2020 Jul; 19(4):243-258. PubMed ID: 32393978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Archived neonatal dried blood spot samples can be used for accurate whole genome and exome-targeted next-generation sequencing.
    Hollegaard MV; Grauholm J; Nielsen R; Grove J; Mandrup S; Hougaard DM
    Mol Genet Metab; 2013; 110(1-2):65-72. PubMed ID: 23830478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of functional disease-causal/susceptible variants identified by whole-genome analyses for the understanding of human diseases.
    Hitomi Y; Tokunaga K
    Proc Jpn Acad Ser B Phys Biol Sci; 2017; 93(9):657-676. PubMed ID: 29129848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solving the molecular diagnostic testing conundrum for Mendelian disorders in the era of next-generation sequencing: single-gene, gene panel, or exome/genome sequencing.
    Xue Y; Ankala A; Wilcox WR; Hegde MR
    Genet Med; 2015 Jun; 17(6):444-51. PubMed ID: 25232854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opportunities and technical challenges in next-generation sequencing for diagnosis of rare pediatric diseases.
    Bacchelli C; Williams HJ
    Expert Rev Mol Diagn; 2016 Oct; 16(10):1073-1082. PubMed ID: 27560481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New genetic tools in the diagnosis of growth defects.
    Dauber A
    Growth Horm IGF Res; 2018 Feb; 38():24-28. PubMed ID: 29157920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Next generation sequencing technologies for rare Mendelian disorders: striking potential and ongoing challenges.
    Hoffjan S
    Mol Cell Probes; 2015 Oct; 29(5):259. PubMed ID: 26257290
    [No Abstract]   [Full Text] [Related]  

  • 18. GeneBreaker: Variant simulation to improve the diagnosis of Mendelian rare genetic diseases.
    Richmond PA; Av-Shalom TV; Fornes O; Modi B; Elliott AM; Wasserman WW
    Hum Mutat; 2021 Apr; 42(4):346-358. PubMed ID: 33368787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of genes for childhood heritable diseases.
    Boycott KM; Dyment DA; Sawyer SL; Vanstone MR; Beaulieu CL
    Annu Rev Med; 2014; 65():19-31. PubMed ID: 24422568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The long tail and rare disease research: the impact of next-generation sequencing for rare Mendelian disorders.
    Shen T; Lee A; Shen C; Lin CJ
    Genet Res (Camb); 2015 Sep; 97():e15. PubMed ID: 26365496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.